ADIPOQ and myeloid sarcoma: This constitutes the basis for the conclusion that abnormalities in the functioning of adipose tissue, manifested as disturbances in the adiponectin/leptin ratio among MS patients, may increase the effects of oxidative stress and significantly increase the unfavorable effects of ongoing inflammation [34].